MyAverix Finance
KQ · Healthcare
Medifron DBT Co. Ltd (065650)
Biotechnology
Medifron DBT Co. Ltd (065650) is listed on KQ in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 065650
Medifron DBT Co. Ltd (065650) — FAQ
What is 065650's P/E ratio?
The price-to-earnings (P/E) ratio for Medifron DBT Co. Ltd (065650) is 18.00 (data as of 2026-03-23).
Does Medifron DBT Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Medifron DBT Co. Ltd (065650). Check the MyAverix Finance app for the latest dividend data.
What sector is Medifron DBT Co. Ltd in?
Medifron DBT Co. Ltd (065650) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 065650 listed on?
065650 is listed on KQ.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.